Concepedia

Daria B. Crittenden

DB

Statistics

Publications

25

Citations

4K

H-Index

21

Active since

2011

Affiliations

Amgen (United States)(Current)

UCB Pharma (Belgium)

New Mexico Clinical Research & Osteoporosis Center

University Hospital of Geneva

Columbia University

Daria B. Crittenden is an author at Amgen (United States) specializing in medicine, osteoporosis, and bone health.

Publications per year

2011–2024

25

Publications

25

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Felicia Cosman, Daria B. Crittenden, Jonathan D. Adachi et al. · New England Journal of Medicine · 2016 · 1.7K citations · Full text

Medicine, Orthopedic Surgery, Pharmacotherapy +17

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

Bente Langdahl, Cesar Libanati, Daria B. Crittenden et al. · The Lancet · 2017 · 467 citations

Medicine, Endocrinology, Pharmacotherapy +14

A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis

Gideon M. Hirschfield, Christopher L. Bowlus, Marlyn J. Mayo et al. · New England Journal of Medicine · 2024 · 235 citations

Medicine, Pharmacology, Pharmacotherapy +10

Colchicine Use Is Associated with Decreased Prevalence of Myocardial Infarction in Patients with Gout

Daria B. Crittenden, Robert A. Lehmann, LAURA SCHNECK et al. · The Journal of Rheumatology · 2012 · 222 citations · Full text

Medicine, Cardiology, Pharmacology +16

Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout

Robert T. Keenan, William R. O’Brien, Kristen H. Lee et al. · The American Journal of Medicine · 2011 · 200 citations

Medicine, Pharmacotherapy, Pharmacy Practice +10

1–5 of 25